D2 vs D3 Lymph Node Dissection for Left Colon Cancer

The efficiency of the D3 lymph node dissection is still controversial for left colon cancer patients. This study will try find difference in 5-year overall survival between D2 and D3 lymph node dissection. Investigation of the functional and short-term outcomes will clarify safety of the D3 lymph node dissection.

Trial Details

NCT ID
NCT04364373
Phase
NA
Sponsor
Russian Society of Colorectal Surgeons
Status
RECRUITING
Cancer Type
Colon Cancer Colorectal Cancer
Interventions
  • Left colon resection
  • Sigmoid colon resection
  • Distal sigmoid colon resection or anterior resection
Locations (sample)
  • Moscow, Russia|55.75204,37.61781

Key Eligibility Criteria

  • Agreement of the patient to participate in trial
  • Colon cancer (only adenocarcinoma )
  • The tumor located between the splenic flexure and rectosigmoid junction
  • Tolerance of chemotherapy

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colon Cancer Colorectal Cancer Trials on Trialify →